All-Trans Retinoic Acid Enhances Matrix Metalloproteinase 2 Expression and Secretion in Human Myeloid Leukemia THP-1 Cells

All-trans retinoic acid (ATRA) is an effective drug for the induction therapy of acute promyelocytic leukemia. However, the treatment is associated with adverse events such as retinoic acid syndrome (RAS) in some patients, whose histologic characteristics included organ infiltration by leukemic cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Vu, Hien Thi, Hoang, Thi Xoan, Kim, Jae Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6129365/
https://www.ncbi.nlm.nih.gov/pubmed/30225259
http://dx.doi.org/10.1155/2018/5971080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6129365/
https://www.ncbi.nlm.nih.gov/pubmed/30225259
http://dx.doi.org/10.1155/2018/5971080

Ejemplares similares